Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses

Open access

Published version of a preprint

Abstract

We still know very little about how the human immune system responds to SARS-CoV-2. Here we construct a SARS-CoV-2 proteome microarray containing 18 out of the 28 predicted proteins and apply it to the characterization of the IgG and IgM antibodies responses in the sera from 29 convalescent patients. We find that all these patients had IgG and IgM antibodies that specifically bind SARS-CoV-2 proteins, particularly the N protein and S1 protein. Besides these proteins, significant antibody responses to ORF9b and NSP5 are also identified. We show that the S1 specific IgG signal positively correlates with age and the level of lactate dehydrogenase (LDH) and negatively correlates with lymphocyte percentage. Overall, this study presents a systemic view of the SARS-CoV-2 specific IgG and IgM responses and provides insights to aid the development of effective diagnostic, therapeutic and vaccination strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-17488-8

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The workflow of SARS-CoV-2 proteome microarray fabrication and serum profiling. a The genome of SARS-CoV-2 and the 28 predicted proteins. b The workflow of proteome microarray fabrication and serum profiling on the microarray.
Fig. 1 The workflow of SARS-CoV-2 proteome microarray fabrication and serum profiling. a The genome of SARS-CoV-2 and the 28 predicted proteins. b The workflow of proteome microarray fabrication and serum profiling on the microarray.CC BY · PubMed Central
Fig. 2 SARS-CoV-2 proteome microarray layout and quality control. a There are 14 identical subarrays on a single microarray. A microarray was incubated with an anti-6xHis antibody to demonstrate the overall microarray quality (green). One subarray was shown. The proteins were printed in quadruplicate. The triangles indicate dilution titers of the same proteins. b Representative subarrays probed with sera of a COVID-19 convalescent and healthy control. The IgG and IgM responses were shown in green and red, respectively. c, d The correlations of the overall IgG and IgM signal intensities between two repeats probed with the same serum. Proteins (n = 93) on the microarray were examined. e Statistics of the Pearson correlation confidence among repeats probed with the same serum. Two serum samples from the convalescent group was examined in three independent experiments. NC negative control, PC positive control; 0.1, 0.2, 0.25, and 0.5 indicate the concentration of these proteins for microarray printing. T Tao Lab, B Hangzhou Bioeast biotech. Co.,Ltd., K Healthcode Co., Ltd., S Sanyou biopharmaceuticals Co.,Ltd., W VACURE l Biotechnology Co.,Ltd., Y Sino biological Co.,Ltd. Expression system: (1) E. coli: All proteins from Tao Lab (T), N Protein _S, N Protein_W; (2) Cell-free: All proteins from Healthcode Co., Ltd. (K), (3) Mammalian: S1_B, S1_S, S-RBD_S, S-RBD_Y.
Fig. 2 SARS-CoV-2 proteome microarray layout and quality control. a There are 14 identical subarrays on a single microarray. A microarray was incubated with an anti-6xHis antibody to demonstrate the overall microarray quality (green). One subarray was shown. The proteins were printed in quadruplicate. The triangles indicate dilution titers of the same proteins. b Representative subarrays probed with sera of a COVID-19 convalescent and healthy control. The IgG and IgM responses were shown in green and red, respectively. c, d The correlations of the overall IgG and IgM signal intensities between two repeats probed with the same serum. Proteins (n = 93) on the microarray were examined. e Statistics of the Pearson correlation confidence among repeats probed with the same serum. Two serum samples from the convalescent group was examined in three independent experiments. NC negative control, PC positive control; 0.1, 0.2, 0.25, and 0.5 indicate the concentration of these proteins for microarray printing. T Tao Lab, B Hangzhou Bioeast biotech. Co.,Ltd., K Healthcode Co., Ltd., S Sanyou biopharmaceuticals Co.,Ltd., W VACURE l Biotechnology Co.,Ltd., Y Sino biological Co.,Ltd. Expression system: (1) E. coli: All proteins from Tao Lab (T), N Protein _S, N Protein_W; (2) Cell-free: All proteins from Healthcode Co., Ltd. (K), (3) Mammalian: S1_B, S1_S, S-RBD_S, S-RBD_Y.CC BY · PubMed Central
Fig. 3 The overall SARS-CoV-2-specific IgG profiles of the 29 convalescent sera against the proteins. Each square indicates the IgG antibody response against the protein (row) in the serum (column). Proteins were shown with names along with concentrations (μg mL−1) and sources. Sera were shown with group information and serum number. NCP Novel Coronavirus Patients or COVID-19 patients, LC lung cancer, NC normal control. Blank means no serum. Three repeats were performed for serum P534 and P535. FI fluorescence intensity.
Fig. 3 The overall SARS-CoV-2-specific IgG profiles of the 29 convalescent sera against the proteins. Each square indicates the IgG antibody response against the protein (row) in the serum (column). Proteins were shown with names along with concentrations (μg mL−1) and sources. Sera were shown with group information and serum number. NCP Novel Coronavirus Patients or COVID-19 patients, LC lung cancer, NC normal control. Blank means no serum. Three repeats were performed for serum P534 and P535. FI fluorescence intensity.CC BY · PubMed Central
Fig. 4 The overall SARS-CoV-2-specific IgM profiles of the 29 convalescent sera against the proteins. Each square indicates the IgM antibody response against the protein (row) in the serum (column). The rest was the same as that of Fig. 3.
Fig. 4 The overall SARS-CoV-2-specific IgM profiles of the 29 convalescent sera against the proteins. Each square indicates the IgM antibody response against the protein (row) in the serum (column). The rest was the same as that of Fig. 3.CC BY · PubMed Central
Fig. 5 IgG responses to S and N proteins. a Box plots of IgG response for S1 and S2 proteins. The proteins labeled with bold and red were overexpression in mammalian cell lines. b Box plots of IgG response for N proteins. For a, b, each dot indicates one serum sample either from the convalescent group (green, n = 29) or the control group (brown, n = 21). Data are represented as boxplots where the middle line is the mean value. The upper and lower hinges are mean values ± SD. P values were calculated by the two-sided t-test. Q values were adjusted p-values using BH method. ***q < 0.001. The exact p-values were shown in Supplementary Data 2. c Pearson correlation coefficient matrix of IgG responses among different S1 and S2 proteins. d–f Correlations of overall IgG responses among different S1 proteins (d), S1 vs. RBD (e) and S1 vs. S2 (f). g One part of a sub-microarray showed the IgG responses of two controls, i.e., LC169 and NC96 against N proteins, N-Cter and N-Nter indicates the C-terminal and N-terminal of N protein, respectively. h, i Correlations of the overall IgG responses among different N proteins (h) and N protein vs. S protein (i). j Statistics of the Pearson correlation coefficients between IgG and IgM profile against constructs of S1 (n = 7), S-RBD (n = 2), S2 (n = 2), and N (n = 9). Data are presented as mean values ± SD. k Correlations between IgG and IgM profile against S1_0.1_W. For d–f, h–k, each dot indicates one serum sample from the convalescent group (n = 29). For f and i, p-values were calculated by the two-sided t-test.
Fig. 5 IgG responses to S and N proteins. a Box plots of IgG response for S1 and S2 proteins. The proteins labeled with bold and red were overexpression in mammalian cell lines. b Box plots of IgG response for N proteins. For a, b, each dot indicates one serum sample either from the convalescent group (green, n = 29) or the control group (brown, n = 21). Data are represented as boxplots where the middle line is the mean value. The upper and lower hinges are mean values ± SD. P values were calculated by the two-sided t-test. Q values were adjusted p-values using BH method. ***q < 0.001. The exact p-values were shown in Supplementary Data 2. c Pearson correlation coefficient matrix of IgG responses among different S1 and S2 proteins. d–f Correlations of overall IgG responses among different S1 proteins (d), S1 vs. RBD (e) and S1 vs. S2 (f). g One part of a sub-microarray showed the IgG responses of two controls, i.e., LC169 and NC96 against N proteins, N-Cter and N-Nter indicates the C-terminal and N-terminal of N protein, respectively. h, i Correlations of the overall IgG responses among different N proteins (h) and N protein vs. S protein (i). j Statistics of the Pearson correlation coefficients between IgG and IgM profile against constructs of S1 (n = 7), S-RBD (n = 2), S2 (n = 2), and N (n = 9). Data are presented as mean values ± SD. k Correlations between IgG and IgM profile against S1_0.1_W. For d–f, h–k, each dot indicates one serum sample from the convalescent group (n = 29). For f and i, p-values were calculated by the two-sided t-test.CC BY · PubMed Central
Fig. 6 IgG response to other SARS-CoV-2 proteins. a Other SARS-CoV-2 proteins that were recognized by IgG from the convalescent sera, in comparison to that of the controls. b, c Anti-ORF9b IgG (b) or anti-NSP5 IgG (c) in the patient and control group. For b, c, each dot indicates one serum sample either from the convalescent group (n = 29) or the control group (n = 21). Data are presented as mean values ± SD. The dashed line indicates cutoff value calculated as mean + 3x SD of the control group. P-values were calculated by the two-sided t-test and q-values were adjusted p-values using BH method. d, e Correlations of the overall IgG responses for N or S1 protein vs. ORF9b (d) or NSP5 (e). For d, e, each dot indicates one serum sample from the convalescent group (n = 29) and p-values were calculated by the two-sided t-test.
Fig. 6 IgG response to other SARS-CoV-2 proteins. a Other SARS-CoV-2 proteins that were recognized by IgG from the convalescent sera, in comparison to that of the controls. b, c Anti-ORF9b IgG (b) or anti-NSP5 IgG (c) in the patient and control group. For b, c, each dot indicates one serum sample either from the convalescent group (n = 29) or the control group (n = 21). Data are presented as mean values ± SD. The dashed line indicates cutoff value calculated as mean + 3x SD of the control group. P-values were calculated by the two-sided t-test and q-values were adjusted p-values using BH method. d, e Correlations of the overall IgG responses for N or S1 protein vs. ORF9b (d) or NSP5 (e). For d, e, each dot indicates one serum sample from the convalescent group (n = 29) and p-values were calculated by the two-sided t-test.CC BY · PubMed Central
Fig. 7 Correlations with clinical characteristics. a–d Correlations of S1 IgG responses with Days after COVID-19 onset (a), Age (b), peak LDH (c), and Ly% (d). For a–d, each dot indicates one serum sample from the convalescent group (n = 29). e S1 IgG responses in male (M, n = 13) and female (F, n = 16) groups. t-test Data are presented as mean values ± SD. For a–e, p-values were calculated by two-sided t-test. f multiple linear regression model for S1 IgG. P-values for coefficient was calculated by two-sided t-test and p-value for regression model was calculated by one-sided F-test. *p < 0.05.
Fig. 7 Correlations with clinical characteristics. a–d Correlations of S1 IgG responses with Days after COVID-19 onset (a), Age (b), peak LDH (c), and Ly% (d). For a–d, each dot indicates one serum sample from the convalescent group (n = 29). e S1 IgG responses in male (M, n = 13) and female (F, n = 16) groups. t-test Data are presented as mean values ± SD. For a–e, p-values were calculated by two-sided t-test. f multiple linear regression model for S1 IgG. P-values for coefficient was calculated by two-sided t-test and p-value for regression model was calculated by one-sided F-test. *p < 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 329

Metadata

Authors
Jiang, H.-W., Li, Y., Zhang, H.-N., Wang, W., Yang, X., Qi, H., Li, H., Men, D., Zhou, J., & Tao, S.-C.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • The Fourth People's Hospital (CN)
  • Chinese Academy of Sciences (CN)
Corresponding author
  • Men, Dong
  • Zhou, Jie
  • Tao, Sheng-ce
Venue
Nature Communications
Published
2020-07-14
Volume
11
Issue
1
Pages
3581-3581
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3045737895
Cited by
329
References
54
Citations by year
2026: 3 · 2025: 7 · 2024: 16 · 2023: 36 · 2022: 71 · 2021: 129 · 2020: 66
FWCI
9.85
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (31900112)
  • Foshan Scientific and Technological Key Project for COVID-19
  • National Key Research and Development Program of China Grant
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
Keywords
SARS-CoV-2, COVID-19 pandemic, proteome microarray, antibody response, IgG, IgM, convalescent patients, S1 protein, nucleocapsid protein, ORF9b, NSP5, age, lactate dehydrogenase, lymphocyte percentage, humoral immunity
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Coronavirus Nucleocapsid Proteins, Coronavirus 3C Proteases, Adult, Antibodies, Viral, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin G, Immunoglobulin M, L-Lactate Dehydrogenase, Male, Middle Aged, Phosphoproteins, Pneumonia, Viral, Viral Nonstructural Proteins, Coronavirus Infections, Nucleocapsid Proteins, Proteome, Protein Array Analysis, Pandemics, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses. https://app.cochat.ai/papers/10.1038/s41467-020-17488-8
The paper
Jiang, H.-W., Li, Y., Zhang, H.-N., Wang, W., Yang, X., Qi, H., Li, H., Men, D., Zhou, J., & Tao, S.-C. (2020). SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses. Nature Communications. https://doi.org/10.1038/s41467-020-17488-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.